Total Payments
$10,543
2024 Payments
$1,569
Companies
29
Transactions
704
Medicare Patients
1,943
Medicare Billing
$311,414
Payment Breakdown by Category
Food & Beverage$10,443 (99.0%)
Education$100.17 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,443 | 699 | 99.0% |
| Education | $100.17 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,771 | 118 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,679 | 105 | $0 (2022) |
| Lundbeck LLC | $865.39 | 78 | $0 (2024) |
| ABBVIE INC. | $817.12 | 62 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $634.00 | 37 | $0 (2024) |
| Alkermes, Inc. | $614.99 | 34 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $555.12 | 44 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $553.90 | 30 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $535.32 | 29 | $0 (2024) |
| Allergan, Inc. | $523.10 | 54 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,569 | 89 | ABBVIE INC. ($407.30) |
| 2023 | $1,309 | 76 | Teva Pharmaceuticals USA, Inc. ($216.74) |
| 2022 | $1,829 | 109 | Alkermes, Inc. ($271.50) |
| 2021 | $1,162 | 77 | Sunovion Pharmaceuticals Inc. ($210.09) |
| 2020 | $1,394 | 103 | Sunovion Pharmaceuticals Inc. ($421.52) |
| 2019 | $1,106 | 82 | Sunovion Pharmaceuticals Inc. ($306.88) |
| 2018 | $1,113 | 83 | Sunovion Pharmaceuticals Inc. ($287.38) |
| 2017 | $1,061 | 85 | Sunovion Pharmaceuticals Inc. ($261.81) |
All Payment Transactions
704 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Neuropsychiatry | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Central Nervous System | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: CNS | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neuropsychiatry | ||||||
| 10/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Neuropsychiatry | ||||||
| 08/27/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 268 | 655 | $126,683 | $48,217 |
| 2022 | 7 | 449 | 1,008 | $194,010 | $73,707 |
| 2021 | 7 | 598 | 1,309 | $246,177 | $98,846 |
| 2020 | 8 | 628 | 1,495 | $259,801 | $90,644 |
Total Patients
1,943
Total Services
4,467
Medicare Billing
$311,414
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 430 | $86,000 | $33,331 | 38.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 124 | $17,960 | $7,261 | 40.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 24 | 30 | $10,590 | $3,355 | 31.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 26 | 32 | $6,868 | $2,615 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 39 | $5,265 | $1,655 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 476 | $95,200 | $36,735 | 38.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 69 | 246 | $32,964 | $13,111 | 39.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 62 | 73 | $25,769 | $9,182 | 35.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 47 | 69 | $13,662 | $5,293 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 104 | $14,040 | $4,928 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 29 | $7,975 | $3,361 | 42.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $4,400 | $1,097 | 24.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 607 | $121,400 | $50,536 | 41.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 72 | 270 | $36,180 | $14,514 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 107 | 183 | $24,705 | $10,329 | 41.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 66 | 83 | $29,299 | $9,908 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 64 | 91 | $18,018 | $7,305 | 40.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 45 | $12,375 | $4,717 | 38.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 21 | 30 | $4,200 | $1,537 | 36.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 219 | 550 | $110,000 | $36,282 | 33.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 145 | 377 | $50,895 | $17,133 | 33.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 68 | 280 | $37,520 | $15,815 | 42.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 51 | 76 | $26,681 | $8,504 | 31.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 47 | 72 | $14,250 | $6,070 | 42.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 62 | 97 | $13,580 | $4,609 | 33.9% |
About Dr. Scott Lance, M.D
Dr. Scott Lance, M.D is a Psychiatry healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467462101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Lance, M.D has received a total of $10,543 in payments from pharmaceutical and medical device companies, with $1,569 received in 2024. These payments were reported across 704 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($10,443).
As a Medicare-enrolled provider, Lance has provided services to 1,943 Medicare beneficiaries, totaling 4,467 services with total Medicare billing of $311,414. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Ashland, KY
- Active Since 08/08/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1467462101
Products in Payments
- REXULTI (Drug) $1,720
- LATUDA (Drug) $1,679
- VRAYLAR (Drug) $1,340
- ABILIFY MAINTENA (Drug) $643.41
- INGREZZA (Drug) $553.90
- ARISTADA (Drug) $445.97
- CAPLYTA (Drug) $443.73
- TRINTELLIX (Drug) $440.35
- HETLIOZ (Drug) $404.87
- AUSTEDO (Drug) $306.82
- Trintellix (Drug) $296.78
- Austedo XR (Drug) $281.68
- Auvelity (Drug) $280.62
- APLENZIN (Drug) $279.66
- SPRAVATO (Drug) $197.34
- LYBALVI (Drug) $169.02
- Dayvigo (Drug) $119.56
- Fanapt (Drug) $111.37
- BRINTELLIX (Drug) $91.27
- ABILIFY ASIMTUFII (Drug) $84.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Ashland
Dr. Manish Parikh, Md, MD
Psychiatry — Payments: $5,205
Psychiatry $5,205
Frances Swarn, M.d, M.D
Psychiatry — Payments: $2,592
Psychiatry $2,592
Anne Zappacosta, Md, MD
Psychiatry — Payments: $1,784
Psychiatry $1,784
Brittany Richardson, Do, DO
Psychiatry — Payments: $1,316
Psychiatry $1,316
Amber Wireman, Do, DO
Psychiatry — Payments: $1,193
Psychiatry $1,193
Veronika Logovinsky, M.d, M.D
Psychiatry — Payments: $880.92
Psychiatry $880.92